| EAN: | 9780128164358 |
|---|---|
| Sachgruppe: | Medizin |
| Sprache: | Englisch |
| Seitenzahl: | 292 |
| Produktart: | Gebunden |
| Herausgeber: | Bonavida, Benjamin |
| Veröffentlichungsdatum: | 29.11.2018 |
| Untertitel: | Volume 4 |
| Schlagworte: | Medical / Nursing |
182,50 €*
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials.